-Swiss drugmaker Novartis has backed away from its pursuit of Cytokinetics, a person familiar with the matter told Reuters, and the U.S. drug developer's shares were down over 21% in afternoon trade.... -January 11, 2024 at 02:35 pm EST - MarketScreener